1. Home
  2. PTCT vs GBTG Comparison

PTCT vs GBTG Comparison

Compare PTCT & GBTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • GBTG
  • Stock Information
  • Founded
  • PTCT 1998
  • GBTG 2014
  • Country
  • PTCT United States
  • GBTG United States
  • Employees
  • PTCT N/A
  • GBTG N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • GBTG Computer Software: Prepackaged Software
  • Sector
  • PTCT Health Care
  • GBTG Technology
  • Exchange
  • PTCT Nasdaq
  • GBTG Nasdaq
  • Market Cap
  • PTCT 4.1B
  • GBTG 3.6B
  • IPO Year
  • PTCT 2013
  • GBTG N/A
  • Fundamental
  • Price
  • PTCT $50.57
  • GBTG $8.26
  • Analyst Decision
  • PTCT Buy
  • GBTG Strong Buy
  • Analyst Count
  • PTCT 14
  • GBTG 3
  • Target Price
  • PTCT $67.14
  • GBTG $9.83
  • AVG Volume (30 Days)
  • PTCT 1.5M
  • GBTG 1.1M
  • Earning Date
  • PTCT 08-07-2025
  • GBTG 08-05-2025
  • Dividend Yield
  • PTCT N/A
  • GBTG N/A
  • EPS Growth
  • PTCT N/A
  • GBTG N/A
  • EPS
  • PTCT 7.72
  • GBTG N/A
  • Revenue
  • PTCT $1,764,929,000.00
  • GBTG $2,440,000,000.00
  • Revenue This Year
  • PTCT $119.89
  • GBTG $2.77
  • Revenue Next Year
  • PTCT N/A
  • GBTG $4.42
  • P/E Ratio
  • PTCT $6.55
  • GBTG N/A
  • Revenue Growth
  • PTCT 96.00
  • GBTG 3.61
  • 52 Week Low
  • PTCT $30.41
  • GBTG $5.78
  • 52 Week High
  • PTCT $58.38
  • GBTG $9.60
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 56.09
  • GBTG 77.71
  • Support Level
  • PTCT $48.09
  • GBTG $7.78
  • Resistance Level
  • PTCT $54.24
  • GBTG $7.96
  • Average True Range (ATR)
  • PTCT 2.37
  • GBTG 0.30
  • MACD
  • PTCT 0.19
  • GBTG 0.07
  • Stochastic Oscillator
  • PTCT 66.83
  • GBTG 98.49

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

Share on Social Networks: